Skip to main content
All lobbying filings

ALBEMARLE CORPORATION

ALBEMARLE CORPORATION filed a Q2 report for ALBEMARLE CORPORATION on July 18, 2025.

Lobbying for ALBEMARLE CORPORATION · Specialty Chemical manufacturer

All filings by ALBEMARLE CORPORATION · Everything ALBEMARLE CORPORATION has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Expenses
$630,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6

Public Law 117-169, Inflation Reduction Act of 2022, issues related to implementation, tax credits and foreign entity of concern

Issues related to trade and mineral supply

Public Law 117-169, Inflation Reduction Act of 2022, issues related to implementation, tax credits and foreign entity of concern

H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law No: 119-4); H.R.4016, Department of Defense Appropriations Act, 2026; issues related to lithium batteries

Issues related to critical minerals development and oil field brine lithium development (Andrew Sady-Kennedy engaged in lobbying only at US House and US Senate)

Issues related to mineral supply (Andrew Sady-Kennedy engaged in lobbying only at US House and US Senate)

 Bills named in this filing 2
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • H.R. 4016
    Department of Defense Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem